Insider Trading activities of Vivus Inc insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vivus Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Vivus Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Vivus Inc since 2005. The reporting company's ticker symbol is VVUS. The reporting company's CIK number is 881524.
The total value of stock buying since 2005 is $11,830,759.
The total value of stock sales since 2005 is $71,356,816.
The total value of stock option exercises since 2005 is $14,691,591.


 1   2 

Table 2. Detailed insider stock purchases, sales, and option exercises of Vivus Inc insiders (VVUS) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2012-08-10 Shortliffe Linda M Dairiki (Director) Option Ex 25,000 4.23 105,750
2012-08-10 Mario Ernest (Director) Buy 5,000 21.50 107,500
2012-08-09 Mario Ernest (Director) Buy 15,000 21.83 327,405
2012-07-18 Slebir John L (VP, General Counsel) Sale 10,000 30.36 303,600
2012-07-18 Slebir John L (VP, General Counsel) Option Ex 10,000 7.57 75,650
2012-07-18 Day Wesley (VP, Clinical Research) Sale 16,800 30.36 510,048
2012-07-18 Marsh Guy P (VP, Operations and General Mgr) Sale 36,191 30.36 1,098,758
2012-07-18 Marsh Guy P (VP, Operations and General Mgr) Option Ex 36,191 4.84 175,055
2012-07-18 Tam Peter Y (President) Sale 25,000 30.95 773,750
2012-07-18 Tam Peter Y (President) Option Ex 25,000 4.25 106,250
2012-07-18 Miller Michael Patrick (Chief Commercial Officer) Sale 25,000 30.36 759,000
2012-07-18 Miller Michael Patrick (Chief Commercial Officer) Option Ex 25,000 10.19 254,750
2012-07-18 Morris Timothy E (VP, Finance and CFO) Sale 25,000 30.36 759,000
2012-07-18 Morris Timothy E (VP, Finance and CFO) Option Ex 25,000 4.23 105,750
2012-07-18 Wilson Leland F (CEO) Sale 100,000 30.36 3,036,000
2012-07-18 Wilson Leland F (CEO) Option Ex 100,000 3.47 347,000
2012-06-27 Miller Michael Patrick (Chief Commercial Officer) Sale 25,000 28.08 701,900
2012-06-27 Miller Michael Patrick (Chief Commercial Officer) Option Ex 25,000 10.19 254,750
2012-06-27 Wilson Leland F (CEO) Sale 50,000 28.00 1,400,000
2012-06-27 Wilson Leland F (CEO) Option Ex 50,000 4.15 207,500
2012-06-19 Tam Peter Y (President) Sale 20,000 27.25 545,000
2012-06-19 Tam Peter Y (President) Option Ex 20,000 3.73 74,600
2012-06-18 Tam Peter Y (President) Sale 20,000 26.45 529,000
2012-06-18 Tam Peter Y (President) Option Ex 20,000 3.73 74,600
2012-06-14 Tam Peter Y (President) Sale 296,250 25.27 7,488,581
2012-06-14 Tam Peter Y (President) Option Ex 236,250 3.93 928,462
2012-06-12 Miller Michael Patrick (Chief Commercial Officer) Sale 25,000 25.00 625,000
2012-06-12 Miller Michael Patrick (Chief Commercial Officer) Option Ex 25,000 10.19 254,750
2012-06-11 Wilson Leland F (CEO) Sale 50,000 25.18 1,259,000
2012-06-11 Wilson Leland F (CEO) Option Ex 50,000 4.15 207,500
2012-03-16 Logan Mark B (Director) Sale 14,000 20.32 284,452
2012-03-16 Logan Mark B (Director) Option Ex 14,000 3.43 48,062
2012-03-15 Marsh Guy P (VP, Operations & General Mgr.) Sale 6,605 20.31 134,147
2012-03-12 Casamento Charles J (Director) Sale 37,000 20.14 745,216
2012-03-12 Casamento Charles J (Director) Option Ex 37,000 8.77 324,601
2012-03-09 Perry Lee (VP & Chief Accounting Officer) Sale 87,623 20.96 1,836,227
2012-03-09 Perry Lee (VP & Chief Accounting Officer) Option Ex 87,623 5.84 511,630
2012-03-08 Shortliffe Linda M Dairiki (Director) Sale 52,000 21.50 1,118,000
2012-03-08 Shortliffe Linda M Dairiki (Director) Option Ex 52,000 4.24 220,272
2012-02-27 Marsh Guy P (VP, Operations and General Mgr) Sale 47,078 22.93 1,079,498
2012-02-27 Marsh Guy P (VP, Operations and General Mgr) Option Ex 47,078 7.48 352,143
2012-02-27 Morris Timothy E (SVP, Finance and CFO) Sale 50,000 23.59 1,179,350
2012-02-27 Morris Timothy E (SVP, Finance and CFO) Option Ex 50,000 5.19 259,500
2012-02-27 Casamento Charles J (Director) Option Ex 36,000 6.49 233,532
2012-02-27 Wilson Leland F (CEO) Sale 50,000 25.00 1,250,000
2012-02-27 Wilson Leland F (CEO) Option Ex 50,000 4.39 219,349
2012-02-24 Morris Timothy E (SVP, Finance and CFO) Sale 25,000 21.55 538,750
2012-02-24 Morris Timothy E (SVP, Finance and CFO) Option Ex 25,000 5.67 141,750
2012-02-23 Perry Lee (VP & Chief Accounting Officer) Sale 171,832 20.69 3,555,204
2012-02-23 Perry Lee (VP & Chief Accounting Officer) Option Ex 171,832 4.70 806,751
2012-02-23 Day Wesley (VP, Clinical Development) Sale 79,958 20.69 1,654,331
2012-02-23 Day Wesley (VP, Clinical Development) Option Ex 79,958 3.93 313,995
2012-02-23 Marsh Guy P (VP, Operations & General Mgr.) Sale 86,777 20.70 1,796,283
2012-02-23 Marsh Guy P (VP, Operations & General Mgr.) Option Ex 86,777 4.38 380,256
2012-02-23 Morris Timothy E (SVP, Finance and CFO) Sale 254,358 20.73 5,271,569
2012-02-23 Morris Timothy E (SVP, Finance and CFO) Option Ex 254,358 4.69 1,192,939
2012-02-23 Wilson Leland F (Chief Executive Officer) Sale 150,000 20.69 3,103,500
2012-02-23 Wilson Leland F (Chief Executive Officer) Option Ex 150,000 4.29 643,500
2012-01-11 Tam Peter Y (President) Sale 27,014 12.00 324,168
2012-01-10 Tam Peter Y (President) Sale 12,386 12.00 148,632
2012-01-09 Perry Lee (VP & Chief Accounting Officer) Sale 39,700 11.75 466,475
2012-01-09 Perry Lee (VP & Chief Accounting Officer) Option Ex 39,700 3.04 120,688
2012-01-09 Day Wesley (VP, Clinical Development) Sale 30,000 11.50 345,000
2012-01-09 Day Wesley (VP, Clinical Development) Option Ex 30,000 3.28 98,400
2011-12-06 Casamento Charles J (Director) Option Ex 25,000 4.23 105,750
2011-11-11 Day Wesley (VP, Clinical Development) Sale 23,442 9.87 231,349
2011-11-11 Day Wesley (VP, Clinical Development) Option Ex 23,442 3.21 75,131
2011-07-11 Tam Peter Y (President) Option Ex 5,000 3.40 17,000
2010-12-17 Day Wesley (VP, Clinical Development) Sale 66,600 9.54 635,497
2010-12-17 Day Wesley (VP, Clinical Development) Option Ex 60,000 3.26 195,600
2010-12-17 Logan Mark B (Director) Sale 20,000 9.52 190,340
2010-12-17 Logan Mark B (Director) Option Ex 20,000 3.93 78,600
2010-12-16 Tam Peter Y (President) Sale 10,000 9.28 92,810
2010-12-16 Tam Peter Y (President) Option Ex 18,750 3.88 72,656
2010-12-15 Shortliffe Linda M Dairiki (Director) Sale 8,000 9.31 74,480
2010-12-15 Shortliffe Linda M Dairiki (Director) Option Ex 8,000 3.96 31,680
2010-12-15 Logan Mark B (Director) Sale 18,000 9.14 164,520
2010-12-15 Logan Mark B (Director) Option Ex 18,000 5.45 98,046
2010-12-15 Wilson Leland F (Chief Executive Officer) Sale 62,000 9.16 568,168
2010-12-15 Wilson Leland F (Chief Executive Officer) Option Ex 100,000 3.88 387,500
2010-07-22 Logan Mark B (Director) Option Ex 8,000 3.96 31,680
2010-06-14 Morris Timothy E (SVP, Finance & CFO) Sale 26,250 12.16 319,278
2010-06-14 Morris Timothy E (SVP, Finance & CFO) Option Ex 26,250 3.13 82,162
2010-05-18 Wilson Leland F (Chief Executive Officer) Sale 50,000 13.00 650,000
2010-03-11 Shortliffe Linda M Dairiki (Director) Sale 8,000 9.26 74,064
2010-03-11 Shortliffe Linda M Dairiki (Director) Option Ex 8,000 5.81 46,504
2010-01-18 Tam Peter Y (President) Option Ex 8,750 4.84 42,385
2010-01-15 Place Virgil A (Chief Scientific Officer) Option Ex 17,500 4.84 84,770
2010-01-15 Wilson Leland F (Chief Executive Officer) Option Ex 70,000 4.84 339,080
2009-11-05 Logan Mark B (Director) Option Ex 8,000 5.81 46,504
2009-09-30 Marsh Guy P (VP, Operations & General Mgr.) Sale 2,630 10.84 28,509
2009-09-30 Marsh Guy P (VP, Operations & General Mgr.) Option Ex 2,630 3.88 10,196
2009-09-25 Marsh Guy P (VP, Operations & General Mgr.) Sale 2,084 10.51 21,902
2009-09-25 Marsh Guy P (VP, Operations & General Mgr.) Option Ex 2,084 6.05 12,608
2009-09-11 Marsh Guy P (VP, Operations & General Mgr.) Sale 34,582 12.05 416,713
2009-09-11 Marsh Guy P (VP, Operations & General Mgr.) Option Ex 34,582 8.08 279,422
2009-09-10 Marsh Guy P (VP, Operations & General Mgr.) Sale 35,000 11.98 419,160
2009-09-10 Marsh Guy P (VP, Operations & General Mgr.) Option Ex 35,000 6.88 240,660
2009-09-09 Perry Lee (VP & Chief Accounting Officer) Sale 12,000 12.10 145,200
2009-09-09 Perry Lee (VP & Chief Accounting Officer) Option Ex 12,000 4.25 51,000
2009-09-09 Marsh Guy P (VP, Operations & General Mgr.) Sale 35,000 10.95 383,250
2009-09-09 Marsh Guy P (VP, Operations & General Mgr.) Option Ex 35,000 6.05 211,750
2009-09-09 Wilson Leland F (President & CEO) Sale 200,000 11.32 2,263,400
2009-08-31 Marsh Guy P (VP, Operations & General Mgr.) Sale 2,630 6.27 16,490
2009-08-31 Marsh Guy P (VP, Operations & General Mgr.) Option Ex 2,630 3.88 10,196
2009-08-24 Marsh Guy P (VP, Operations & General Mgr) Sale 521 6.78 3,532
2009-08-24 Marsh Guy P (VP, Operations & General Mgr) Option Ex 521 3.73 1,943
2009-07-31 Marsh Guy P (VP, Operations & General Mgr.) Sale 19,831 7.40 146,789
2009-07-31 Marsh Guy P (VP, Operations & General Mgr.) Option Ex 19,831 4.05 80,355
2009-07-30 Marsh Guy P (VP, Operations & General Mgr.) Sale 35,000 7.56 264,495
2009-07-30 Marsh Guy P (VP, Operations & General Mgr.) Option Ex 35,000 4.67 163,380
2009-07-27 Marsh Guy P (VP, Operations & General Mgr.) Sale 300 7.50 2,250
2009-07-27 Marsh Guy P (VP, Operations & General Mgr.) Option Ex 300 4.84 1,453
2009-07-23 Marsh Guy P (VP, Operations & General Mgr.) Sale 521 6.97 3,630
2009-07-23 Marsh Guy P (VP, Operations & General Mgr.) Option Ex 521 3.73 1,943
2009-07-22 Wilson Leland F (President & CEO) Sale 50,000 7.00 350,000
2009-06-30 Marsh Guy P (VP, Operations & General Mgr.) Sale 2,631 6.00 15,786
2009-06-30 Marsh Guy P (VP, Operations & General Mgr.) Option Ex 2,631 3.88 10,200
2009-06-26 Marsh Guy P (VP, Operations & General Mgr.) Sale 11,867 6.01 71,285
2009-06-26 Marsh Guy P (VP, Operations & General Mgr.) Option Ex 11,867 4.08 48,381
2009-06-15 Marsh Guy P (VP, Operations & General Mgr.) Sale 4,158 6.00 24,948
2009-06-15 Marsh Guy P (VP, Operations & General Mgr.) Option Ex 4,158 4.25 17,671
2009-06-12 Marsh Guy P (VP, Operations & General Mgr.) Sale 35,000 6.02 210,805
2009-06-12 Marsh Guy P (VP, Operations & General Mgr.) Option Ex 35,000 3.81 133,525
2009-06-12 Wilson Leland F (President & CEO) Sale 50,000 6.10 305,050
2008-12-15 Shortliffe Linda M Dairiki (Director) Sale 32,000 5.92 189,376
2008-12-15 Shortliffe Linda M Dairiki (Director) Option Ex 32,000 3.75 120,000
2008-12-12 Wilson Leland F (President & CEO) Sale 30,000 6.41 192,360
2008-12-01 Tam Peter Y (SVP, Product & Corporate Dev.) Option Ex 27,500 2.69 73,892
2008-12-01 Wilson Leland F (President & CEO) Option Ex 150,000 2.69 403,050
2008-09-11 Place Virgil A (Chief Scientific Officer) Sale 5,950 9.00 53,550
2008-09-02 Wilson Leland F (President & CEO) Sale 50,000 8.56 428,000
2008-08-19 Place Virgil A (Cheif Scientific Officer) Option Ex 40,000 2.69 107,480
2008-08-12 Marsh Guy P (VP, Operations & General Mgr.) Sale 75,000 8.56 642,225
2008-08-12 Marsh Guy P (VP, Operations & General Mgr.) Option Ex 75,000 4.13 309,975
2008-08-11 Marsh Guy P (VP, Operations & General Mgr.) Sale 113,138 8.42 952,735
2008-08-11 Marsh Guy P (VP, Operations & General Mgr.) Option Ex 113,138 3.75 423,814
2008-08-01 Wilson Leland F (President and CEO) Option Ex 31,250 .00 0
2008-07-09 Wilson Leland F (President and CEO) Option Ex 31,250 .00 0
2008-05-23 Wilson Leland F (President & CEO) Sale 70,000 6.50 455,000
2008-05-22 Wilson Leland F (President & CEO) Sale 15,585 6.50 101,302
2008-05-14 Day Wesley (VP, Clinical Research) Buy 3,297 4.17 13,758
2008-05-14 Tam Peter Y (Senior VP, Product &) Buy 3,727 4.17 15,552
2008-05-14 Wilson Leland F (President & CEO) Buy 1,295 4.17 5,404
2008-04-07 Wilson Leland F (President and CEO) Sale 4,415 6.50 28,697
2008-04-04 Wilson Leland F (President and CEO) Sale 10,000 6.50 65,000
2008-01-16 Wilson Leland F (President & CEO) Sale 65,721 5.99 393,603
2008-01-14 Wilson Leland F (President & CEO) Sale 7,500 6.00 45,000
2007-11-28 Wilson Leland F (President & CEO) Sale 94,375 5.35 504,811
2007-11-28 Wilson Leland F (President & CEO) Option Ex 100,000 3.67 367,100
2007-11-14 Day Wesley (VP, Clinical Research) Buy 3,104 4.23 13,139
2007-11-14 Tam Peter Y (Senior VP, Product &) Buy 1,495 4.23 6,328
2007-11-14 Wilson Leland F (President & CEO) Buy 1,216 4.23 5,147
2007-09-07 Place Virgil A (Chief Scientific Officer) Sale 7,781 5.09 39,644
2007-09-05 Place Virgil A (Chief Scientific Officer) Sale 10,000 5.21 52,110
2007-09-04 Place Virgil A (Chief Scientific Officer) Sale 10,000 5.29 52,900
2007-08-31 Place Virgil A (Chief Scientific Officer) Sale 10,000 5.31 53,070
2007-08-30 Place Virgil A (Chairman & CSO) Sale 10,000 5.29 52,870
2007-08-29 Place Virgil A (Chairman & CSO) Sale 15,000 5.16 77,460
2007-08-27 Place Virgil A (Chairman & CSO) Sale 10,000 5.14 51,420
2007-08-24 Place Virgil A (Chairman & CSO) Sale 10,000 5.07 50,720
2007-08-09 Wilson Leland F (President & CEO) Sale 7,500 5.55 41,625
2007-08-08 Wilson Leland F (President & CEO) Sale 7,500 5.50 41,250
2007-08-01 Wilson Leland F (President & CEO) Sale 7,500 5.62 42,150
2007-05-14 Day Wesley (VP, Clinical Research) Buy 4,244 3.06 12,986
2007-05-14 Tam Peter Y (Senior VP, Product &) Buy 4,793 3.06 14,666
2007-05-14 Wilson Leland F (President & CEO) Buy 1,661 3.06 5,082
2007-04-30 Wilson Leland F (President & CEO) Sale 200,000 5.58 1,116,000
2006-12-01 Nida Terry (VP, Worldwide Marketing/) Sale 30,000 4.00 120,090
2006-12-01 Nida Terry (VP, Worldwide Marketing/) Option Ex 30,000 2.94 88,110
2006-11-30 Wilson Leland F (President and CEO) Sale 44,999 4.09 184,045
2006-11-30 Wilson Leland F (President and CEO) Option Ex 44,999 2.94 132,162
2006-11-14 Day Wesley (VP, Clinical Research) Buy 2,198 2.99 6,576
2006-11-14 Nida Terry (VP, Worldwide Marketing/) Buy 4,427 2.99 13,245
2006-11-14 Tam Peter Y (Senior VP, Product &) Buy 1,535 2.99 4,592
2006-11-14 Dietrich John W (Vice President, R & D) Buy 254 2.99 759
2006-05-14 Nida Terry (VP, Worldwide Marketing/) Buy 5,319 2.65 14,105
2006-05-14 Tam Peter Y (Senior VP, Product &) Buy 5,641 2.65 14,959
2006-05-14 Dietrich John W (Vice President, R & D) Buy 629 2.65 1,668
2006-03-02 Day Wesley (VP, Clinical Research) Buy 4,000 3.40 13,600
2005-10-31 Tam Peter Y (&) Buy 3,300 2.31 7,629
2005-10-31 Dietrich John W (D) Buy 1,380 2.31 3,190
2005-04-29 Nida Terry (VP, Worldwide Market) Buy 2,742 2.29 6,292
2005-04-29 Tam Peter Y (&) Buy 5,431 2.29 12,464
2005-04-29 Dietrich John W (D) Buy 1,270 2.29 2,914
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of VVUS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Vivus Inc (symbol VVUS, CIK number 881524) see the Securities and Exchange Commission (SEC) website.